Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Enteromedics Inc (ETRM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 30,957
  • Shares Outstanding, K 6,910
  • Annual Sales, $ 790 K
  • Annual Income, $ -23,360 K
  • 36-Month Beta 3.04
  • Price/Sales 39.93
  • Price/Cash Flow 0.00
  • Price/Book 1.75

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.30 +1.40%
on 07/18/17
5.28 -17.42%
on 06/27/17
-0.62 (-12.45%)
since 06/23/17
3-Month
4.00 +9.00%
on 04/25/17
6.45 -32.40%
on 05/23/17
-0.23 (-5.01%)
since 04/24/17
52-Week
1.75 +149.14%
on 01/04/17
30.41 -85.66%
on 01/10/17
-11.04 (-71.69%)
since 07/22/16

Most Recent Stories

More News
EnteroMedics passes European patent certificate for new technology for treating obesity

Medical devices company EnteroMedics Inc (NASDAQ:ETRM) revealed on Thursday the receipt of the European patent titled "Treatment of excess weight by neural downregulation in combination with compositions"...

ETRM : 4.36 (-2.68%)
EnteroMedics Added to Russell Microcap® Index

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the Company will join the Russell Microcap®...

ETRM : 4.36 (-2.68%)
EnteroMedics Announces vBloc Therapy to be Presented by Keynote Speaker at Major International Obesity Conference

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Scott Shikora, M.D, F.A.C.S., F.A.S.M.B.S.,...

ETRM : 4.36 (-2.68%)
Medical Equipment Stocks on Investors' Radar -- Abbott Labs, Boston Scientific, Medtronic, and EnteroMedics

Stock-Callers.com today has lined up for assessment the following Medical Appliances and Equipment equities: Abbott Laboratories (NYSE: ABT), Boston Scientific Corp. (NYSE: BSX), Medtronic PLC (NYSE: MDT),...

ABT : 50.80 (-0.08%)
BSX : 27.62 (unch)
SCHW : 41.96 (-0.45%)
ETRM : 4.36 (-2.68%)
MDT : 85.09 (-0.09%)
EnteroMedics Announces the Acquisition of the Gastric Vest System

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices treating obesity, metabolic diseases and other gastrointestinal disorders, announced today that it has acquired the Gastric Vest System(TM)...

ETRM : 4.36 (-2.68%)
EnteroMedics Announces First vBloc® Neurometabolic Therapy Implant at McGuire Veterans Affairs Medical Center

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the McGuire...

ETRM : 4.36 (-2.68%)
EnteroMedics to Host First Quarter 2017 Conference Call

EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, will host a conference call...

ETRM : 4.36 (-2.68%)
Medical Equipment Stocks on Investors' Radar -- Abbott, Boston Scientific, Medtronic, and EnteroMedics

Stock-Callers.com revisits the Medical Appliances and Equipment industry, which includes companies that are engaged in the manufacture of medical instruments such as dental and surgical appliances. For...

ABT : 50.80 (-0.08%)
BSX : 27.62 (unch)
ETRM : 4.36 (-2.68%)
MDT : 85.09 (-0.09%)
EnteroMedics' vBloc® Neurometabolic Therapy Recognized at 2017 Edison Awards

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced it has been named...

ETRM : 4.36 (-2.68%)
Technical Reports on Medical Equipment Stocks -- EnteroMedics, Abbott Labs, Boston Scientific, and Medtronic

Today at Stock-Callers.com, investors' attention is directed to four equities in the Medical Appliances and Equipment space, and they are: EnteroMedics Inc. (NASDAQ: ETRM), Abbott Laboratories (NYSE: ABT),...

ABT : 50.80 (-0.08%)
BSX : 27.62 (unch)
ETRM : 4.36 (-2.68%)
MDT : 85.09 (-0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

EnteroMedics Inc. was established to develop and commercialize a new therapeutic platform for treating a wide range of acute and chronic diseases that are mediated by the vagal nerves. Due to the large unmet need for more effective surgical management of obesity, and following an in-depth analysis of...

See More

Support & Resistance

2nd Resistance Point 4.52
1st Resistance Point 4.44
Last Price 4.36
1st Support Level 4.30
2nd Support Level 4.24

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.